Navigation Links
Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis

aries; refer to the individual country product label for complete information. For U.S. safety information, visit http://www.HUMIRA.com.

Serious infections, sepsis, rare cases of tuberculosis (TB), and opportunistic infections, including fatalities, have been reported with the use of TNF antagonists, including HUMIRA. Many of the serious infections have occurred in patients on concomitant immunosuppressive therapy that, in addition to their RA could predispose them to infections. Patients must be monitored closely for infections, including tuberculosis, before, during and after treatment with HUMIRA. Treatment should not be initiated in patients with active infections until infections are controlled. HUMIRA should not be used by patients with active TB or other severe infections such as sepsis and opportunistic infections. Patients who develop new infections while using HUMIRA should be monitored closely. HUMIRA should be discontinued if a patient develops a new serious infection until infections are controlled. Physicians should exercise caution when considering use of HUMIRA in patients with a history of recurring infection or with underlying conditions that may predispose patients to infections.

TNF-blocking agents have been associated with reactivation of hepatitis B (HBV) in patients who are chronic carriers of the virus. Some cases have been fatal. Patients at risk for HBV infection should be evaluated for prior evidence of HBV infection before initiating HUMIRA.

The combination of HUMIRA and anakinra is not recommended.

TNF antagonists, including HUMIRA, have been associated in rare cases with demyelinating disease and serious allergic reactions. Rare reports of pancytopenia including aplastic anemia have been reported with TNF-blocking agents. Adverse events of the haematologic system, including medically significant cytopenia have been infrequently reported with HUMIRA.

'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
2. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
3. Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment
4. ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO
5. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
6. Isotechnika Announces Interim Three Month Data from Phase 2b Kidney Transplant Trial
7. Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting
8. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
Post Your Comments:
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... how to optimize a product,s web presence to ... critical. Brand websites, in particular, must meet the ... in regulations and culture. According ... LLC, more than half of the participating companies ...
(Date:12/19/2014)... -- Monarch America Inc. (OTCQB: CANK) ("Monarch America" or the ... this review of the Company,s recent achievements and strategic ... this past year, we achieved many of our early ... say that Monarch America is in a stronger and ... stated Eric Hagen , CEO of Monarch America ...
(Date:12/19/2014)... WORTH, Texas , December 18, 2014 /PRNewswire/ ... a networked software application/module that is used to ... related images. RIS comprises a patient tracking and ... system. The integration of RIS with HIS and ... used for patient registration and patient scheduling, patient ...
Breaking Medicine Technology:Building a Best-in-Class Pharma Global Brand Website 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... 16, 2011 PDL BioPharma, Inc. (PDL) (NASDAQ: ... 15, 2011, regular quarterly dividend payment of $0.15 per share to ... the record date. About PDL BioPharma ... by doing so, enabled the discovery of a new generation of ...
... 2011 The U.S. Food and Drug Administration today ... adult patients who have had a kidney transplant. ... immunosuppressants (medications that suppress the immune system) -- ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Nulojix is ...
Cached Medicine Technology:FDA Approves Nulojix for Kidney Transplant Patients 2FDA Approves Nulojix for Kidney Transplant Patients 3
(Date:12/21/2014)... (PRWEB) December 22, 2014 Weddingshe.com, an ... occasion gowns, has recently released its new selection of ... models are made according to the newest fashion trends. ... stunning dresses for cocktail parties . All of ... 80 percent off. We are making every effort to ...
(Date:12/21/2014)... December 21, 2014 Khanna Vision Institute ... guest at the Aspen Helicopters holiday event for underprivileged ... Santa with sleigh, flown by an aspen helicopter pilot. ... only Santa with sleigh was visible.(please see accompanying video). ... night. Dr.Khanna has helped many pilots with Pi in ...
(Date:12/21/2014)... AngelWeddingDress.com’s new collection of 2015 spring wedding dresses ... new designs in this collection, and all of them ... AngelWeddingDress.com promises to provide the most fashionable designs ... many fashion trends come and go. If ladies have ... AngelWeddingDress.com is ready to assist. , “These new ...
(Date:12/21/2014)... Dennis Thompson HealthDay Reporter ... smokers find e-cigarettes less addictive than traditional cigarettes, new research ... as they did regular cigarettes, thousands of ex-smokers said they ... and irritable over their need to smoke, researchers reported. ... was significantly less for e-cig use than for tobacco use," ...
(Date:12/21/2014)... 2014 The number of Mirena lawsuits ... litigation underway in New Jersey, Bernstein Liebhard LLP reports. ... claims involving the birth control IUD have now been ... filed by women who allege spontaneous migration of the ... perforations and other complications they were inadequately warned about ...
Breaking Medicine News(10 mins):Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3
... International Diabetes Federation (IDF) BRIDGES translational research grant ... seeks to reduce the risk of for people ... The community based diabetes prevention programme will determine ... research studies of lifestyle interventions for diabetes prevention ...
... YORK (May 29, 2008) -- Physician-scientists from NewYork-Presbyterian ... research findings at the American Society of Clinical ... June 3. Among the most significant presentations are ... OncoVEXGM-CSF for Patients With Unresectable Metastatic Melanoma , ...
... N.J., May 30 Lutronic, Inc., one of,the ... systems,announced today that its MOSAIC eCO2 system, the ... with the deep,ablative features of a CO2 laser, ... and,clearance., With intuitive touch-screen software, the powerful ...
... The world was stunned by the,news of ... 70,000 dead and,thousands more injured and homeless. In ... Wheelchair Mission (FWM), a non-profit,organization dedicated to transforming ... with Holistic Integrated Service Foundation (HIS),a nonprofit in ...
... Find New Video ,Milestones in Oncology, Presentations at ... The Society for Translational Oncology,(STO) is pleased to ... uniquely valuable video presentations for practicing,oncologists., (Logo: ... made on the occasion of the 2008 Annual ...
... with advanced cancer were more likely than whites to ... greater preference among blacks for life-extending treatment even in ... study led by researchers at Dana-Farber Cancer Institute in ... the annual meeting of the American Society of Clinical ...
Cached Medicine News:Health News:International Diabetes Federation grant supports study to prevent type 2 diabetes in India 2Health News:NYP/Columbia physician-scientists present at ASCO 44th annual meeting 2Health News:NYP/Columbia physician-scientists present at ASCO 44th annual meeting 3Health News:NYP/Columbia physician-scientists present at ASCO 44th annual meeting 4Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 2Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 3Health News:Free Wheelchair Mission to Distribute 4,400 Wheelchairs to China Earthquake Victims 2Health News:Society for Translational Oncology Launches Updated Website 2Health News:Black patients with terminal cancer more likely to choose aggressive care at end of life 2
... is the first truely web-based solution on the ... POC (managed from the lab) and Critical Care ... of AegisPOC ensures that all groups have the ... in the manner best suited to them. Through ...
... ultrasonic technology. When managing glaucoma patients and ... to use the best technology available. ... analog and digital technology that utilizes ultrasound ... other ultrasonic pachymeters in the market. This ...
...
...
Medicine Products: